drugset / Trial / NCT00196391
A Trial to Evaluate DR-2021 in Women With Secondary Amenorrhea
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a multicenter trial to compare the effectiveness of 4 doses of DR-2021 with placebo and oral micronized progesterone in inducing withdrawal bleeding in women with secondary amenorrhea.
Timeline
- Start
- 2005-09
- Primary completion
- 2007-04
- Completion
- 2007-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DR-2021 | Unknown | — | — |